Frank Morgan
Stock Analyst at RBC Capital
(1.29)
# 3,576
Out of 4,959 analysts
57
Total ratings
45.45%
Success rate
-9.11%
Average return
Main Sectors:
Stocks Rated by Frank Morgan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EHTH eHealth | Maintains: Sector Perform | $13 → $11 | $3.84 | +186.46% | 4 | Nov 25, 2024 | |
| UHS Universal Health Services | Maintains: Sector Perform | $222 → $211 | $185.58 | +13.70% | 4 | Oct 28, 2024 | |
| HUM Humana | Maintains: Outperform | $415 → $353 | $299.51 | +17.86% | 4 | Apr 25, 2024 | |
| CI The Cigna Group | Upgrades: Outperform | $327 → $354 | $304.35 | +16.31% | 4 | Feb 5, 2024 | |
| AVAH Aveanna Healthcare Holdings | Downgrades: Sector Perform | $7 → $3 | $7.47 | -59.84% | 2 | Nov 21, 2022 | |
| ACHC Acadia Healthcare Company | Maintains: Outperform | $84 → $94 | $22.44 | +318.89% | 1 | Aug 1, 2022 | |
| HCA HCA Healthcare | Maintains: Outperform | $256 → $249 | $404.97 | -38.51% | 3 | Jul 25, 2022 | |
| THC Tenet Healthcare | Maintains: Outperform | $104 → $99 | $179.50 | -44.85% | 2 | Jul 25, 2022 | |
| SEM Select Medical Holdings | Maintains: Outperform | $47 → $42 | $13.42 | +212.97% | 1 | Mar 7, 2022 | |
| CHE Chemed | Maintains: Outperform | $609 → $579 | $459.05 | +26.13% | 3 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $150 → $30 | $5.62 | +433.81% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $13 → $3 | $2.69 | +11.52% | 3 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $42 → $35 | $25.60 | +36.72% | 2 | Nov 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $44 → $37 | $25.17 | +47.00% | 3 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $97 → $107 | $71.30 | +50.07% | 1 | Nov 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $13 → $9 | $7.31 | +23.12% | 1 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $137 → $124 | $118.41 | +4.72% | 1 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $96 | $172.44 | -44.33% | 3 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $113 → $111 | $140.36 | -20.92% | 3 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $473 → $476 | $307.42 | +54.84% | 1 | Oct 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $65 → $41 | $10.40 | +294.23% | 2 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $7 → $8 | $7.72 | +3.63% | 4 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $102 → $104 | $122.83 | -15.33% | 1 | Jul 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $12 → $21 | $2.76 | +660.87% | 1 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $18 → $20 | $23.64 | -15.40% | 1 | Aug 10, 2018 |
eHealth
Nov 25, 2024
Maintains: Sector Perform
Price Target: $13 → $11
Current: $3.84
Upside: +186.46%
Universal Health Services
Oct 28, 2024
Maintains: Sector Perform
Price Target: $222 → $211
Current: $185.58
Upside: +13.70%
Humana
Apr 25, 2024
Maintains: Outperform
Price Target: $415 → $353
Current: $299.51
Upside: +17.86%
The Cigna Group
Feb 5, 2024
Upgrades: Outperform
Price Target: $327 → $354
Current: $304.35
Upside: +16.31%
Aveanna Healthcare Holdings
Nov 21, 2022
Downgrades: Sector Perform
Price Target: $7 → $3
Current: $7.47
Upside: -59.84%
Acadia Healthcare Company
Aug 1, 2022
Maintains: Outperform
Price Target: $84 → $94
Current: $22.44
Upside: +318.89%
HCA Healthcare
Jul 25, 2022
Maintains: Outperform
Price Target: $256 → $249
Current: $404.97
Upside: -38.51%
Tenet Healthcare
Jul 25, 2022
Maintains: Outperform
Price Target: $104 → $99
Current: $179.50
Upside: -44.85%
Select Medical Holdings
Mar 7, 2022
Maintains: Outperform
Price Target: $47 → $42
Current: $13.42
Upside: +212.97%
Chemed
Mar 4, 2022
Maintains: Outperform
Price Target: $609 → $579
Current: $459.05
Upside: +26.13%
Mar 3, 2022
Downgrades: Sector Perform
Price Target: $150 → $30
Current: $5.62
Upside: +433.81%
Feb 8, 2022
Maintains: Sector Perform
Price Target: $13 → $3
Current: $2.69
Upside: +11.52%
Nov 17, 2021
Maintains: Sector Perform
Price Target: $42 → $35
Current: $25.60
Upside: +36.72%
Nov 10, 2021
Maintains: Outperform
Price Target: $44 → $37
Current: $25.17
Upside: +47.00%
Nov 4, 2021
Maintains: Outperform
Price Target: $97 → $107
Current: $71.30
Upside: +50.07%
Nov 3, 2021
Maintains: Outperform
Price Target: $13 → $9
Current: $7.31
Upside: +23.12%
Nov 3, 2021
Maintains: Outperform
Price Target: $137 → $124
Current: $118.41
Upside: +4.72%
Oct 29, 2021
Maintains: Outperform
Price Target: $100 → $96
Current: $172.44
Upside: -44.33%
Oct 29, 2021
Maintains: Sector Perform
Price Target: $113 → $111
Current: $140.36
Upside: -20.92%
Oct 15, 2021
Maintains: Outperform
Price Target: $473 → $476
Current: $307.42
Upside: +54.84%
Aug 18, 2021
Maintains: Outperform
Price Target: $65 → $41
Current: $10.40
Upside: +294.23%
Aug 9, 2021
Maintains: Sector Perform
Price Target: $7 → $8
Current: $7.72
Upside: +3.63%
Jul 29, 2021
Maintains: Outperform
Price Target: $102 → $104
Current: $122.83
Upside: -15.33%
Jun 10, 2021
Upgrades: Outperform
Price Target: $12 → $21
Current: $2.76
Upside: +660.87%
Aug 10, 2018
Maintains: Outperform
Price Target: $18 → $20
Current: $23.64
Upside: -15.40%